Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTILS.L Share News (TILS)

  • There is currently no data for TILS

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK Shareholder Meetings Calendar - Next 7 Days

Fri, 25th Sep 2020 16:05

Monday 28 September 
Diageo PLCAGM
Time Out Group PLCAGM
Mulberry Group PLCAGM
Van Elle Holdings PLCAGM
Mereo BioPharma Group PLCAGM
Christie Group PLCAGM
Galileo Resources PLCAGM
Eddie Stobart Logistics PLCGM re financial statements
Challenger Acquisitions LtdAGM
Avon Rubber PLCGM re Team Wendy purchase
Tuesday 29 August 
PV Crystalox Solar PLCGM re tender offer
Raven Property Group LtdGM re tender offer
Novacyt SAAGM
Gama Aviation PLCAGM
Ince Group PLCAGM
IMImobile PLCAGM
Brickability Group PLCAGM
DCD Media PLCAGM
Jaywing PLCAGM
Carclo PLCAGM
Arcontech Group PLCAGM
Amigo Holdings PLCGM re Richmond Group resolutions
Rockfire Resources PLCGM re articles of association amendment
Appreciate Group PLCAGM
Augmentum Fintech PLCAGM
Wednesday 30 September 
Active Energy Group PLCAGM
Anglesey Mining PLCAGM
Catena Group PLCAGM
Chenvari Capital Solutions LtdEGM re base currency change to euro
City of London Group PLCAGM
Clipper Logistics PLCAGM
Creightons PLCAGM
daVictus PLCAGM
Distribution Finance Capital Holdings PLCAGM
HML Holdings PLCAGM
IntegraFin Holdings PLCGM re hybrid general meetings
Marlowe PLCAGM
Mobile Tornado Group PLCAGM
Motif Bio PLCAGM
Powerhouse Energy Group PLCAGM
Purplebricks Group PLCAGM
Renishaw PLCAGM
San Leon Energy PLCAGM
Sosandar PLCAGM
Studio Retail Group PLCAGM
Tekmar Group PLCAGM
TheWorks.co.uk PLCAGM
Yew Grove REIT PLCEGM re gearing level
Thursday 1 October 
Abbey PLCAGM
Anglo African Oil & Gas PLCAGM
Boston International Holdings PLCAGM
Friday 2 October 
Cobra Resources PLCGM re power to allot shares
Just Eat Takeaway.com NVEGM re Grubhub acquisition
NCC Group PLCAGM
Tiziana Life Sciences PLCGM re Accustem Sciences Ltd demerger
  
Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
18 Nov 2020 15:11

UK DIRECTOR DEALINGS SUMMARY: 888 CEO Sells GBP780,000 In Shares

UK DIRECTOR DEALINGS SUMMARY: 888 CEO Sells GBP780,000 In Shares

Read more
11 Nov 2020 20:17

UK TRADING UPDATE SUMMARY: Mereo To Delist From AIM Amid Nasdaq Focus

UK TRADING UPDATE SUMMARY: Mereo To Delist From AIM Amid Nasdaq Focus

Read more
2 Nov 2020 18:14

IN BRIEF: Tiziana To Start Brazil Clinical Trial For Covid-19 Patients

IN BRIEF: Tiziana To Start Brazil Clinical Trial For Covid-19 Patients

Read more
29 Oct 2020 16:04

Court gives Tiziana capital reduction the nod

(Sharecast News) - Biotechnology company Tiziana Life Sciences announced on Thursday that the capital reduction required for the demerger of StemPrintER Sciences, and to enable the ultimate allotment of Accustem Sciences shares to its shareholders, has been sanctioned by the court.

Read more
30 Sep 2020 12:18

UK EARNINGS SUMMARY: City Pub In Signs Of Recovery After Tough Interim

UK EARNINGS SUMMARY: City Pub In Signs Of Recovery After Tough Interim

Read more
17 Sep 2020 15:51

IN BRIEF: Tiziana To Kick Off Clinical Study On Foralumab

IN BRIEF: Tiziana To Kick Off Clinical Study On Foralumab

Read more
16 Sep 2020 11:55

Tiziana Plans 2020 London IPO Of StemPrintER, SPARE Assets

Tiziana Plans 2020 London IPO Of StemPrintER, SPARE Assets

Read more
24 Aug 2020 14:33

IN BRIEF: Tiziana Life Sciences Gets US Patent On TZLS-501 In Covid-19

IN BRIEF: Tiziana Life Sciences Gets US Patent On TZLS-501 In Covid-19

Read more
24 Aug 2020 14:19

Tiziana gets US patent for 'TZLS-501' antibody

(Sharecast News) - Biotechnology company Tiziana Life Sciences announced on Monday that the United States Patent and Trademark Office (USPTO) has granted a patent for methods and use of fully human monoclonal antibody 'TZLS-501' that recognised both IL-6 receptor (IL-6R) and IL-6 receptor complex with IL-6 (IL-6R/IL-6) for prophylactic and therapeutic intervention for human diseases.

Read more
21 Aug 2020 09:34

Tiziana Life Sciences Gets US Patent For Milciclib In Cancer

Tiziana Life Sciences Gets US Patent For Milciclib In Cancer

Read more
18 Aug 2020 18:36

IN BRIEF: Tiziana Gets US Patent For Foralumab As Crohn's Treatment

IN BRIEF: Tiziana Gets US Patent For Foralumab As Crohn's Treatment

Read more
5 Aug 2020 22:03

UK TRADING UPDATE SUMMARY: Airtel And Telkom Abort Kenya Combination

UK TRADING UPDATE SUMMARY: Airtel And Telkom Abort Kenya Combination

Read more
4 Aug 2020 19:16

UK TRADING UPDATE SUMMARY: Brickability Recovering Well From Pandemic

UK TRADING UPDATE SUMMARY: Brickability Recovering Well From Pandemic

Read more
4 Aug 2020 11:07

Tiziana inks four deals for development of Covid-19 treatment

(Sharecast News) - Biotechnology company Tiziana Life Sciences has signed agreements with four contract research organisations, it announced on Tuesday, to expedite the clinical development of 'TZLS-501' - a novel, fully human anti-interleukin-6 receptor (anti-IL6R) monoclonal antibody (mAb) for the treatment of Covid-19 patients.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.